Search Results - "Behrendt, C.‑A." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Editor's Choice – Assessment of International Outcomes of Intact Abdominal Aortic Aneurysm Repair over 9 Years

Editor's Choice – Assessment of International Outcomes of Intact Abdominal Aortic Aneurysm Repair over 9 Years

by Budtz-Lilly, J., Venermo, M., Debus, S., Behrendt, C.-A., Altreuther, M., Beiles, B., Szeberin, Z., Eldrup, N., Danielsson, G., Thomson, I., Wigger, P., Björck, M., Loftus, I., Mani, K.
Published in European journal of vascular and endovascular surgery (01.07.2017)

Get full text

Journal Article

Big data in vascular surgery: registries, international collaboration and future directions

Big data in vascular surgery: registries, international collaboration and future directions

by Sutzko, D. C., Mani, K., Behrendt, C.‐A., Wanhainen, A., Beck, A. W.
Published in European journal of internal medicine (01.07.2020)

Get full text

Journal Article

Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines: Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg

Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines: Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg

by Behrendt, C.-A, Rieß, H.C, Heidemann, F, Diener, H, Rohlffs, F, Hohnhold, R, Debus, E.S
Published in European journal of vascular and endovascular surgery (01.02.2017)

Get full text

Journal Article

Commentary on “Renal Complications After EVAR With Suprarenal Versus Infrarenal Fixation Among All Users and Routine Users”

Commentary on “Renal Complications After EVAR With Suprarenal Versus Infrarenal Fixation Among All Users and Routine Users”

by Debus, E.S., Behrendt, C.-A.
Published in European journal of vascular and endovascular surgery (01.09.2017)

Get full text

Journal Article

Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products—The example of paclitaxel

Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products—The example of paclitaxel

by Behrendt, C.‑A., Rother, U., Rümenapf, G., Uhl, C., Görtz, H., Böckler, D.
Published in Gefässchirurgie (01.12.2020)

Get full text

Journal Article

Corrigendum to “Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines: Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg” [Eur J Vasc Endovasc Surg 53 (2016) 215–222]

Corrigendum to “Radiation Dosage for Percutaneous PAD Treatment is Different in Cardiovascular Disciplines: Results From an Eleven Year Population Based Registry in the Metropolitan Area of Hamburg” [Eur J Vasc Endovasc Surg 53 (2016) 215–222]

by Behrendt, C.-A, Rieß, H.C, Heidemann, F, Diener, H, Rohlffs, F, Hohnhold, R, Debus, E.S
Published in European journal of vascular and endovascular surgery (01.06.2017)

Get full text

Journal Article

Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers

Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers

by Behrendt, C.-A., Heidemann, F., Haustein, K., Grundmann, R. T., Debus, E. S.
Published in Gefässchirurgie (01.03.2017)

Get full text

Journal Article

Complex endovascular treatment of intact aortic aneurysms: An analysis of health insurance claims data

Complex endovascular treatment of intact aortic aneurysms: An analysis of health insurance claims data

by Behrendt, C.-A., Rieß, H. C., Schwaneberg, T., Heidemann, F., Tsilimparis, N., Larena-Avellaneda, A.‑A., Diener, H., Kölbel, T., Debus, E. S.
Published in Gefässchirurgie (2018)

Get full text

Journal Article

Peripheral arterial disease (PAD) – A challenging manifestation of atherosclerosis

Peripheral arterial disease (PAD) – A challenging manifestation of atherosclerosis

by Nordanstig, J., Behrendt, C.A., Bradbury, A.W., de Borst, G.J., Fowkes, FGR, Golledge, J., Gottsater, A., Hinchliffe, R.J., Nikol, S., Norgren, L.
Published in Preventive medicine (01.06.2023)

Get full text

Journal Article

Prognostic impact of disease-related complications in asymptomatic mitral regurgitation: a health insurance claims analysis

Prognostic impact of disease-related complications in asymptomatic mitral regurgitation: a health insurance claims analysis

by Acar, L, Behrendt, C A, Baldus, S, Falk, V, Smetak, N, Nzomo, M Mboulla, Marschall, U, Girdauskas, E
Published in Clinical research in cardiology (28.08.2024)

Get full text

Journal Article

The first impact and collateral damage of the corona pandemic in interdisciplinary vascular medicine: vaccination campaign for patients with peripheral arterial disease?

The first impact and collateral damage of the corona pandemic in interdisciplinary vascular medicine: vaccination campaign for patients with peripheral arterial disease?

by Behrendt, C-A, Larena-Avellaneda, A
Published in Gefässchirurgie (2021)

Get full text

Journal Article

Quality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?

Quality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?

by Peters, F., Kreutzburg, T., Kuchenbecker, J., Marschall, U., Remmel, M., Dankhoff, M., Trute, H.‑H., Repgen, T., Debus, E. S., Behrendt, C.-A.
Published in Gefässchirurgie (01.12.2020)

Get full text

Journal Article

Der erste Einschlag und Kollateralschäden der Corona-Pandemie in der interdisziplinären Gefäßmedizin: Impfkampagnen für Patienten mit peripherer arterieller Verschlusskrankheit?

Der erste Einschlag und Kollateralschäden der Corona-Pandemie in der interdisziplinären Gefäßmedizin: Impfkampagnen für Patienten mit peripherer arterieller Verschlusskrankheit?

by Behrendt, C.-A., Larena-Avellaneda, A.
Published in Gefässchirurgie (01.05.2021)

Get full text

Journal Article

Die Sache mit den Mindestmengen und der Zentralisierung bei der Behandlung des Bauchaortenaneurysmas

Die Sache mit den Mindestmengen und der Zentralisierung bei der Behandlung des Bauchaortenaneurysmas

by Behrendt, C.-A., Trenner, M., Kölbel, T.
Published in Gefässchirurgie (01.10.2020)

Get full text

Journal Article

Was ist die Realität hinter der Real-World-Evidenz?

Was ist die Realität hinter der Real-World-Evidenz?

by Behrendt, C.-A.
Published in Gefässchirurgie (01.02.2019)

Get full text

Journal Article

Vier Jahre IDOMENEO: Was hat Mozarts Oper der interdisziplinären Behandlung der peripheren arteriellen Verschlusskrankheit gebracht?

Vier Jahre IDOMENEO: Was hat Mozarts Oper der interdisziplinären Behandlung der peripheren arteriellen Verschlusskrankheit gebracht?

by Behrendt, C.-A., Debus, E. S.
Published in Gefässchirurgie (01.02.2021)

Get full text

Journal Article

Statine in der Behandlung der peripheren arteriellen Verschlusskrankheit: Weltweit am häufigsten verschrieben, nur eben nicht bei denen, die sie am meisten benötigen

Statine in der Behandlung der peripheren arteriellen Verschlusskrankheit: Weltweit am häufigsten verschrieben, nur eben nicht bei denen, die sie am meisten benötigen

by Behrendt, C.-A., Peters, F.
Published in Gefässchirurgie (01.12.2020)

Get full text

Journal Article

Jedes Bein zählt – Die zentrale Rolle der Gefäßchirurgie bei der Behandlung einer Volkskrankheit

Jedes Bein zählt – Die zentrale Rolle der Gefäßchirurgie bei der Behandlung einer Volkskrankheit

by Behrendt, C.-A., Gombert, A.
Published in Gefässchirurgie (01.09.2020)

Get full text

Journal Article

Die Grenzen der Randomisierung und das Medical Device Epidemiology Network (MDEpiNet)

Die Grenzen der Randomisierung und das Medical Device Epidemiology Network (MDEpiNet)

by Behrendt, C.-A., Debus, E. S.
Published in Gefässchirurgie (01.05.2019)

Get full text

Journal Article

Randomisierte kontrollierte Studien und Real-World-Evidence in der Marktzulassung und Überwachung von Hochrisikoprodukten – Das Beispiel Paclitaxel

Randomisierte kontrollierte Studien und Real-World-Evidence in der Marktzulassung und Überwachung von Hochrisikoprodukten – Das Beispiel Paclitaxel

by Behrendt, C.-A., Rother, U., Rümenapf, G., Uhl, C., Görtz, H., Böckler, D.
Published in Gefässchirurgie (01.03.2021)

Get full text

Journal Article

1
2
3
4
5
6
Next
[6]